Reuters logo
BRIEF-Paratek Pharmaceuticals, U.S. Department of defense enter research agreement
October 11, 2016 / 12:32 PM / a year ago

BRIEF-Paratek Pharmaceuticals, U.S. Department of defense enter research agreement

Oct 11 (Reuters) - Paratek Pharmaceuticals Inc

* Paratek Pharmaceuticals Inc - Paratek, U.S. Department of defense enter research agreement to study omadacycline against biodefense pathogens

* Paratek Pharmaceuticals - co will provide omadacycline and technical expertise to support Usamriid’s conduct of pre-clinical pharmacokinetic studies Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below